On March 14, 2022, Adlarity (donepezil hydrochloride) received FDA approval for the treatment of patients with mild, moderate, or severe Alzheimer’s dementia. Adlarity is as effective as other cholinesterase inhibitors.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.